We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories

168 hedge funds and large institutions have $1.3B invested in Dr. Reddy's Laboratories in 2014 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 62 increasing their positions, 50 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 13

24% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 50

6% more funds holding

Funds holding: 159168 (+9)

1.98% more ownership

Funds ownership: 73.92%75.89% (+2%)

1% less capital invested

Capital invested by funds: $1.31B → $1.3B (-$17.9M)

Holders
168
Holders Change
+9
Holders Change %
+5.66%
% of All Funds
4.48%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
26
Increased
62
Reduced
50
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fisher Asset Management
1
Fisher Asset Management
Washington
$210M +$8.35M +793,520 +4%
CBOA
2
Commonwealth Bank of Australia
Australia
$123M +$4.35M +413,520 +4%
BG
3
BlackRock Group
United Kingdom
$78.1M -$3.42M -325,190 -4%
AQR Capital Management
4
AQR Capital Management
Connecticut
$70.8M +$41.8M +3,970,175 +130%
Vanguard Group
5
Vanguard Group
Pennsylvania
$69.5M +$1.31M +124,780 +2%
Schroder Investment Management Group
6
Schroder Investment Management Group
United Kingdom
$65.3M +$12.4M +1,180,750 +22%
SAM
7
Sectoral Asset Management
Quebec, Canada
$38.5M +$1.47M +140,110 +4%
Fidelity International
8
Fidelity International
Bermuda
$37.7M -$51.7M -4,915,045 -57%
JP Morgan Chase
9
JP Morgan Chase
New York
$36.5M +$1.67M +159,005 +5%
CCM
10
Causeway Capital Management
California
$30.6M +$22.9M +2,176,060 +259%
Acadian Asset Management
11
Acadian Asset Management
Massachusetts
$29.4M +$17.5M +1,660,430 +133%
Prudential Financial
12
Prudential Financial
New Jersey
$21.8M -$1.93M -183,000 -8%
Morgan Stanley
13
Morgan Stanley
New York
$20.8M +$1.56M +147,780 +8%
State Street
14
State Street
Massachusetts
$20.6M -$97.1K -9,225 -0.4%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$20.1M +$3.85M +365,720 +22%
CS
16
Credit Suisse
Switzerland
$20.1M +$1.87M +178,070 +10%
Arrowstreet Capital
17
Arrowstreet Capital
Massachusetts
$17.6M -$30.6M -2,905,785 -62%
HGI
18
Hansberger Growth Investors
Wisconsin
$17.6M +$18.3M +1,742,215 New
TAM
19
Todd Asset Management
Kentucky
$17.4M -$942K -89,445 -5%
Northern Trust
20
Northern Trust
Illinois
$17M -$531K -50,440 -3%
TRSOTSOK
21
Teachers Retirement System of the State of Kentucky
Kentucky
$16.6M -$990K -94,000 -5%
UBS AM
22
UBS AM
Illinois
$15.6M -$781K -74,200 -5%
TGA
23
Trilogy Global Advisors
Florida
$12.9M -$5.21K -495 -0%
RFC
24
Russell Frank Company
Washington
$11.7M +$1.36M +129,370 +12%
SO
25
STRS Ohio
Ohio
$11.3M

RDY Hedge Fund Activity: Q4 2014 in Review

168 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q4 2014, worth a combined $1.3B — down 1.4% from $1.31B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new RDY positions and 13 closed out — a net gain of 13 holders — while 62 added to existing stakes and 50 trimmed.

The largest buyer was AQR Capital Management, adding an estimated $41.8M. The largest seller was Fidelity International, cutting an estimated $51.7M.

  • 168 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q4 2014, up from 159 in Q3 2014.
  • Funds reported $1.3B of Dr. Reddy's Laboratories stock for Q4 2014, down 1.4% quarter-over-quarter.
  • 26 funds opened new Dr. Reddy's Laboratories positions in Q4 2014 and 13 closed out, a net change of +13 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q4 2014 was AQR Capital Management, an estimated $41.8M added.
  • The largest Dr. Reddy's Laboratories seller in Q4 2014 was Fidelity International, an estimated $51.7M sold.

Based on aggregated 13F filings for Q4 2014.